For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests.
In blood cancers that develop in the bone marrow, an important clue to a patient’s survival may lie in the bones themselves. Myelodysplastic syndromes (MDS), a group of cancers that primarily affect older adults, interfere with the body’s ability to produce healthy blood cells.
Treatment typically focuses on managing anemia, monitoring blood counts, and providing transfusions when necessary. However, new research suggests that bone health, an often-overlooked aspect of MDS care, may reveal important information about patients’ overall health and prognosis.
In a three-year study involving 111 patients with MDS and 84 age-matched control participants, researchers found that people with MDS had significantly lower bone density at the outset and continued to lose bone mass over time. More notably, patients who already had osteoporosis at the beginning of the study also had poorer overall survival. Although the findings do not establish a cause-and-effect relationship, they point to a potentially important connection between bone deterioration and blood cancer outcomes.
“In patients with MDS, the bone-aging process seems to be sped up,” says Prof. Lorenz Hofbauer, director of the University Center for Healthy Aging at Dresden University Hospital.

MDS becomes more common with age
MDS is among the most common cancers of the blood-forming system. Several thousand people receive an MDS diagnosis in Germany each year. Its incidence rises from approximately 4 to 5 cases per 100,000 people in the general population to more than 30 per 100,000 among people older than 70.
“The results are crucial to our understanding of aging processes,” says Hofbauer. “MDS occurs primarily in elderly individuals, precisely during a phase of life in which bone mass, muscle strength, and physical reserves also decline. Often, there is a chronic, subtle inflammatory process present without there being any apparent cause or infection. In addition, MDS is frequently associated with heart attacks and Alzheimer’s disease.”

A genetic clue connects blood and bone
Within blood-forming cells, a specific mutation in the DNMT3A gene was associated with lower bone density, providing another connection for researchers to investigate between blood formation and bone health. Participants with low bone density or osteoporosis were also more likely to have low calcium levels.
Hofbauer initiated BoHemE in 2016 with Prof. Uwe Platzbecker, Chief Medical Officer of Dresden University Hospital and a specialist in hematology and oncology. The study involved Dresden and Leipzig University Hospitals, along with other partners in Germany.
The findings open opportunities to investigate how blood formation, aging, and bone metabolism influence one another. This is a systems medicine approach, which examines relationships among biological systems and clinical diseases. Collaboration among specialists in blood disorders, bone health, orthopedics, trauma surgery, computer science, and evidence-based medicine could help uncover further connections and support both research and patient care, particularly for older adults with complex conditions.
“The message of the BoHemE study is clear: If you want to treat MDS comprehensively, you should also keep an eye on bone health,” says Hofbauer.
“Strong bones, a high degree of mobility, and a maintained quality of life are part of a healthy aging process and should be systematically taken into account during the diagnosis and ongoing management of MDS. The Osteoporosis Center at Dresden University Hospital provides suitable treatment options for the individualized management of bone diseases in MDS patients.”
Reference: “Bone health in myelodysplastic neoplasms: results from the prospective longitudinal BoHemE study” by Heike Weidner, Elena Tsourdi, Anne Sophie Platzbecker, Martina Rauner, Ulrike Baschant, Maria G. Ledesma-Colunga, Karolina Basiak, Katja Sockel, Ekaterina Balaian, Susann Winter, Anna Harig, Klaus H. Metzeler, Katharina S. Götze, Dominic Brauer, Nicole Modler, Michael Cross, Marie Schneider, Jörg Lützner, Andreas Roth, Thomas Zerjatke, Gabriele Müller, Uwe Platzbecker and Lorenz C. Hofbauer, 9 October 2026, Leukemia.
DOI: 10.1038/s41375-026-03125-8
The study was funded with EUR 1.8 million over a period of three years by the CHOICE project of the German Consortium for Translational Cancer Research (DKTK) and the German Cancer Research Center (DKFZ), Heidelberg.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
A sceptical guide to AI agents in drug discovery
In conversation with Dr Eric Ma, Senior Principal Data Scientist at Moderna, Dr Raminderpal Singh examines what AI agents are actually good for, where the lock-in hides and why expertise has become more valuable [...]
Study identifies new targets for antiviral drugs against coronaviruses
A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, including [...]
“Nearly Everybody Had Given Up” – Scientists Finally Solve a 60-Year Chemistry Mystery
After more than six decades of failed attempts, chemists have achieved a breakthrough involving a class of molecules long considered too unstable to isolate. Chemists have succeeded in isolating a group of molecules that [...]
Depression Symptoms Improved in Just 48 Hours After a Single Psychedelic Dose
A single dose of psilocybin produced rapid antidepressant effects in a small Swedish clinical trial, with improvements lasting for weeks. A single dose of psilocybin, the psychedelic compound found in magic mushrooms, produced rapid [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Human Bodies Are Producing Two Billion Tons of CO2 a Year
A new study reveals that the amount of carbon dioxide produced by human metabolism has increased dramatically over three decades. The carbon dioxide produced by human bodies as they convert food into energy increased [...]
A Hidden DNA Mechanism Could Explain How 20% of Human Cancers Develop
Researchers have identified an unexpected molecular vulnerability in cancers carrying BAF mutations. Mutations found in roughly 20% of human cancers may promote tumor growth by changing how DNA is organized inside cells. Researchers have [...]
Ebola kills over 5,300 in fastest-growing outbreak on record
Africa’s latest Ebola outbreak has killed nearly 5,400 people, the vast majority of them in the Democratic Republic of Congo (DRC), according to the continent’s top health agency. Africa Centres for Disease Control and [...]
China makes early progress in using sound waves to stimulate damaged brains
Chinese researchers are testing whether focused ultrasound can help restore consciousness in patients with severe brain injuries, adding to a growing international effort to use sound waves to stimulate deep brain structures without surgery. [...]
Micro-drones fly through the body thanks to ultrasound
At the EPFL, micro-drones have been developed that can be moved without a motor or battery.No motors, no batteries, no electronics on board, just small cavities that convert sound waves into thrust: this is [...]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]















